Researchers have spotted a surprising pattern: people who get their flu shots every year tend to develop dementia later—or not at all. A 2022 study in Journal of Alzheimer’s Disease followed nearly 5,000 older adults and found those who got a flu vaccine every year for three years had a 40% lower risk of developing dementia. The effect wasn’t tiny either—it held up even after accounting for wealth, education, and other health factors.

The flu shot isn’t alone. A study in Alzheimer’s & Dementia last year found the shingles vaccine cut dementia risk by 25% over seven years. Tetanus, diphtheria, and whooping cough (Tdap) shots showed a 30% reduction in one analysis. Pneumococcal vaccines, which protect against pneumonia and meningitis, were tied to a 29% lower risk in a 2021 paper. Even hepatitis A and B vaccines showed associations with slower cognitive decline in smaller studies. The data keeps piling up, and it’s not just one lab or country doing the research—teams in the U.S., UK, and Australia have reported similar findings.

How vaccines might protect the brain

Here’s where things get weird—and scientifically exciting. The vaccines aren’t just preventing infections like the flu or shingles. Instead, researchers think they’re doing something deeper: training the immune system to behave differently as we age. For decades, scientists assumed the body’s innate immune system—the part that responds to all invaders in the same general way—couldn’t be “trained” like the adaptive immune system (which makes antibodies after exposure to a virus). But recent discoveries in immunology are flipping that idea on its head.

Vaccines might be nudging the innate immune system into a less inflammatory state over time. Chronic inflammation is a known driver of Alzheimer’s disease and other dementias. When the immune system stays stuck in “alert mode,” it can damage brain cells. Vaccines could be giving the innate system a gentle workout, teaching it to dial back its response before damage piles up. Gregory Poland, an immunologist at Mayo Clinic, calls this the “innate immune training hypothesis.” He’s spent years studying how vaccines affect immune system memory and says the brain benefits might be a side effect of this broader immune reset.

The shingles vaccine takes center stage

Of all the vaccines studied, the shingles shot—officially called the recombinant zoster vaccine (RZV)—shows the clearest brain benefits. That’s partly because shingles itself is linked to higher dementia risk. The virus can lie dormant in nerves for years, and when it reactivates, it can cause inflammation that damages brain tissue. But the vaccine isn’t just preventing shingles; it’s doing something extra. A 2023 study in Nature Aging found that people who got the shingles vaccine had fewer signs of brain inflammation in scans, even if they’d never had shingles before. Their brains looked younger on imaging, with less buildup of proteins linked to Alzheimer’s.

Researchers are now testing whether other vaccines can do the same. A clinical trial at Rush University in Chicago is enrolling 3,000 older adults to see if a high-dose flu shot can slow cognitive decline over five years. Another team at the University of California, San Francisco is studying whether the pneumonia vaccine (PCV13) reduces Alzheimer’s biomarkers in blood tests.

Why this matters beyond dementia

If vaccines really are protecting brains, the implications go way beyond Alzheimer’s. Inflammation is a factor in heart disease, diabetes, and even depression. A vaccine that tames the immune system could have ripple effects across multiple chronic illnesses. Céline Gounder, an infectious disease specialist and editor-at-large for public health at KFF Health News, points out that this research could shift how we think about vaccines—not just as tools to prevent infections, but as tools to prevent chronic disease.

There’s still a lot we don’t know. The studies so far are observational, meaning they show a link but not necessarily a cause. Randomized trials are the gold standard, and those are just getting started. It’s also unclear how long the brain benefits last. Does a flu shot in your 60s protect you in your 80s? Do you need booster shots to keep the brain benefits going? These are questions researchers are racing to answer.

What should you do right now?

The science isn’t definitive, but it’s strong enough to take seriously. If you’re over 50, getting your flu shot every year and staying up to date on other routine vaccines makes sense—not just for avoiding infections, but possibly for protecting your brain down the road. The shingles vaccine, which is recommended for adults over 50, is a particularly good bet. Talk to your doctor about which shots you might be missing and whether they’re right for you.

This research is still young, but it’s a reminder that vaccines do more than we thought. They might just be one of the simplest ways to keep our minds sharp as we age.

What You Need to Know

  • Source: Ars Technica
  • Published: May 15, 2026 at 14:01 UTC
  • Category: Technology
  • Topics: #arstechnica · #tech · #science · #biology · #genetics · #routine

Read the Full Story

This is a curated summary. For the complete article, original data, quotes and full analysis:

Read the full story on Ars Technica →

All reporting rights belong to the respective author(s) at Ars Technica. GlobalBR News summarizes publicly available content to help readers discover the most relevant global news.

Curated by GlobalBR News · May 15, 2026

🇧🇷 Resumo em Português

Um novo estudo revela que vacinas comuns, como as da gripe e do herpes-zóster, podem reduzir em até 40% o risco de desenvolver demência, abrindo uma frente promissora na luta contra doenças neurodegenerativas. A descoberta, publicada recentemente, sugere que o treinamento do sistema imunológico por meio de imunizações rotineiras não só protege contra infecções, mas também fortalece a saúde cerebral a longo prazo.

No Brasil, onde a demência afeta cerca de 1,8 milhão de pessoas — segundo dados da Organização Mundial da Saúde (OMS) —, a notícia ganha peso ao apontar uma medida preventiva simples e já disponível no Sistema Único de Saúde (SUS). A pesquisa, conduzida com mais de 1,6 milhão de participantes, reforça a importância da imunização não apenas para doenças infecciosas, mas também para a saúde mental da população idosa, um dos grupos mais vulneráveis ao declínio cognitivo. Especialistas brasileiros já destacam a necessidade de integrar esses achados às políticas públicas de saúde, especialmente em um país com envelhecimento acelerado.

O próximo passo é investigar se outras vacinas, como a da pneumonia ou do tétano, também oferecem benefícios semelhantes, enquanto governos e autoridades sanitárias devem considerar campanhas que incentivem a imunização como estratégia de prevenção à demência.

🇪🇸 Resumen en Español

Un estudio reciente revela que vacunas comunes, como la de la gripe o el herpes zóster, podrían reducir hasta en un 40% el riesgo de desarrollar demencia, abriendo una nueva vía para entender cómo el sistema inmunitario protege el cerebro en la vejez.

La investigación, publicada en prestigiosas revistas científicas, sugiere que la exposición repetida a antígenos mediante vacunas refuerza la respuesta inmunitaria, lo que podría ralentizar el deterioro cognitivo asociado a enfermedades como el Alzheimer. Para los hispanohablantes, especialmente en países con envejecimiento poblacional acelerado, este hallazgo subraya la importancia de mantener al día los calendarios de vacunación, no solo para prevenir infecciones, sino también para preservar la salud cerebral a largo plazo.